{"pmcid": "PMC11730665", "article_title": "Comparative efficacy and safety of sitagliptin or gliclazide combined with metformin in treatment-naive patients with type 2 diabetes: A single-center, prospective, randomized, controlled, noninferiority study with genetic polymorphism analysis", "ground_truth": ["rs1799853", "rs4664443", "rs7754840", "rs3765467", "rs2285676", "rs2909451", "rs6923761", "rs163184"], "response": "```json\n[\n    \"rs2909451\",\n    \"rs4664443\",\n    \"rs3765467\",\n    \"rs2285676\",\n    \"rs6923761\",\n    \"rs163184\",\n    \"rs7754840\",\n    \"rs756992\",\n    \"rs1799853\",\n    \"rs1057910\"\n]\n```", "had_paper_context": true, "model": "gpt-4o", "predicted": ["rs1057910", "rs163184", "rs1799853", "rs2285676", "rs2909451", "rs3765467", "rs4664443", "rs6923761", "rs756992", "rs7754840"], "true_positives": ["rs163184", "rs1799853", "rs2285676", "rs2909451", "rs3765467", "rs4664443", "rs6923761", "rs7754840"], "false_negatives": [], "recall": 1.0, "parse_failure": false}
{"pmcid": "PMC12080641", "article_title": "Sociodemographic, clinical, and genetic factors associated with self-reported antidepressant response outcomes in the UK Biobank", "ground_truth": ["CYP2C19 ultrarapid metabolizer", "CYP2C19 poor metabolizer", "CYP2C19 intermediate metabolizer"], "response": "```json\n[\n    \"CYP2C19 poor metabolizer\"\n]\n```", "had_paper_context": true, "model": "gpt-4o", "predicted": ["CYP2C19 poor metabolizer"], "true_positives": ["CYP2C19 poor metabolizer"], "false_negatives": ["CYP2C19 intermediate metabolizer", "CYP2C19 ultrarapid metabolizer"], "recall": 0.3333333333333333, "parse_failure": false}
